STAT

OCTOBER 14, 2024

Biotech investors have been buzzing around new areas of drug development this year, such as the red-hot obesity market. In the first half of 2024, venture capitalists pledged more than $1.7 But there’s one field that has seen an even more significant amount of activity: autoimmune diseases.

Immunity 363

Immunity Immunization Drug Development 363

STAT

MARCH 20, 2025

  CEO Albert Bourla made a “pragmatic and thoughtful” assessment of the company when he approached Baum in early 2024, Baum told the crowd at STAT’s Breakthrough Summit East Thursday. Pfizer’s R&D team has created effective medicines, he assessed. They just haven’t done so with revenue in mind.

Drug Development 223

Drug Development 223

pharmaphorum

JULY 22, 2024

Rare Disease Diagnostics: Advancing Orphan Drug Development through Precision Testing Mike.Hammerton Mon, 22/07/2024 - 08:00 Bookmark this

Drug Development 111

Drug Development 111

STAT

DECEMBER 12, 2024

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma.    There’s more to life than protein folding. Read the rest…

Drug Development 320

Drug Development 320

STAT

DECEMBER 3, 2024

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. A survey of 2024 headlines regarding AI’s use in drug discovery paints a less-than-rosy picture. This is the first in the series.

Drug Development 353

Drug Development 353

STAT

JANUARY 11, 2024

JPM Week is finally drawing to a close, sending the drug industry’s many financiers scattering from San Francisco to their respective homes and ski destinations. In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout.

Drug Pricing 278

Drug Pricing Drug Development 278

STAT

OCTOBER 22, 2024

  The three parents took the stage at the 2024 STAT Summit to talk about the challenges of trying to find treatments for rare diseases — from securing funding to translating research in animals to humans to commercial barriers. But they’ve all done so with the goal of helping to treat their children’s rare diseases. 

Drug Development 336

Drug Development 336

Express Pharma

FEBRUARY 7, 2025

This is higher than the last 12-month (January 2024 to December 2024) average of 99 deals worth $14 billion. Kardigan Inc, a heart health company, secured $300 million in series A funding to modernise cardiovascular drug development. The healthcare industry reported 107 mergers and acquisitions (M&A) deals worth $29.2

Drug Development 97

Drug Development 97

pharmaphorum

JANUARY 25, 2024

Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.

Drug Development 115

Drug Development 115

STAT

JANUARY 17, 2024

Recursion, a biotechnology firm that uses machine learning for drug development and and which was announcing that it is rolling out AI-driven drug discovery software with tech giant Nvidia, decided to seize the moment. It was going to rain.

Drug Development 347

Drug Development 347

STAT

DECEMBER 1, 2023

Data are expected in the first half of 2024. Pfizer said it would not move twice-daily danuglipron into Phase 3 trials, but that instead it would focus on a once-daily formulation, which is currently undergoing pharmacokinetic studies. Continue to STAT+ to read the full story…

Drug Development 350

Drug Development 350

PharmaVoice

OCTOBER 29, 2024

Pharma pros driving drug development and access for patients with high unmet needs.

Drug Development 113

Drug Development 113

FDA Law Blog: Biosimilars

APRIL 8, 2025

Leading FDAs implementationof the Drug Competition Action Plan (DCAP). The DCAP was an initiative launched in 2017 to remove barriers to generic drug development, approval, and market entry (see our previous post here ). facilitating the twice annual updates to the Off-Patent, Off-Exclusivity List ).

Documentation 142

Documentation Labelling Drug Development 142

European Pharmaceutical Review

DECEMBER 30, 2023

This activity is expected to continue in 2024, with increasing need for biopharma to access innovation through collaboration and dealmaking to offset looming patent challenges. “In Referencing the EY Firepower report 2023 , Baral highlights several key fundamentals that point to increased dealmaking in 2024.

Drug Development 105

Drug Development 105

STAT

MAY 22, 2024

Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation , drugs are coming to market faster than ever.

Pharmaceutical Companies 302

Pharmaceutical Companies Pharmaceutical Companies Drug Development 302

pharmaphorum

JANUARY 29, 2024

4th Ligase Targeting Drug Development Summit 2024 Mike.Hammerton Mon, 29/01/2024 - 13:27 Bookmark this

Drug Development 52

Drug Development 52

pharmaphorum

SEPTEMBER 28, 2023

2nd Molecular Glue Drug Development Summit 2024 Mike.Hammerton Thu, 28/09/2023 - 10:08 Bookmark this

Drug Development 52

Drug Development 52

European Pharmaceutical Review

JANUARY 2, 2024

According to results from a survey by GlobalData, the top challenges for the pharmaceutical industry in 2024 will be inflation, geopolitical conflict and drug pricing pressures. Data outcomes revealed that most respondents from Pharma considered that drug pricing and reimbursement constraints will have a negative impact in 2024.

Drug Pricing 102

Drug Pricing Drug Development 102

PharmExec

NOVEMBER 15, 2023

Pharm Exec’s 19th annual report on the trends of the day in drug development examines the surging investment in new treatments and advances for so-called “first-world” conditions, capturing the landscape of five expanding therapeutic areas: weight loss, osteoarthritis, Alzheimer’s disease, COPD, and psychedelics.

Drug Development 110

Drug Development 110

STAT

SEPTEMBER 25, 2023

That could change if the Federal Reserve lowers interest rates and if more biotechs successfully go public in 2024, according to cautiously optimistic observers. Japan’s health ministry has approved Leqembi, an Alzheimer’s drug developed by Eisai and Biogen, Reuters explains.

Drug Development 244

Drug Development 244

STAT

OCTOBER 27, 2023

The plan is to increase investment in its drug-development pipeline and cut costs, and the split could take place as early as the fourth quarter of 2024.

Diabetes 285

Diabetes Drug Development 285

Outsourcing Pharma

NOVEMBER 1, 2024

At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the advanced AbZelectPRO platform and ThioBridge linker technology.

Drug Development 80

Drug Development 80

Express Pharma

DECEMBER 28, 2023

Healthcare industry professionals scored cell and gene therapy (CGT) as the industry trend to have the greatest impact on the pharmaceutical industry in 2024, in a recent survey launched by GlobalData. The post Cell and gene therapy will be top industry trend for pharma in 2024: GlobalData appeared first on Express Pharma.

Drug Development 105

Drug Development 105

Express Pharma

JULY 21, 2024

4) A streamlined regulatory framework for drug development and approval is very important to get drugs approval quicker, but maintains the high safety standards patients deserve. The post Pharma sector gears up for Budget 2024-25; Calls for innovation and regulatory reforms appeared first on Express Pharma.

Biosimilars 105

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 105

pharmaphorum

SEPTEMBER 11, 2024

4th Mitochondrial Dysfunction Drug Development Summit Mike.Hammerton Wed, 11/09/2024 - 10:50 Bookmark this

Drug Development 52

Drug Development 52

pharmaphorum

APRIL 25, 2024

9th Microbiome Movement Drug Development Summit Mike.Hammerton Thu, 25/04/2024 - 09:09 Bookmark this

Drug Development 52

Drug Development 52

PharmaTech

MARCH 28, 2025

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T.

Drug Development 52

Drug Development 52

pharmaphorum

SEPTEMBER 11, 2024

8th Annual Complement-Based Drug Development Summit Mike.Hammerton Wed, 11/09/2024 - 10:38 Bookmark this

Drug Development 52

Drug Development 52

pharmaphorum

NOVEMBER 7, 2024

Welcome to the Molecular Glue Drug Development Summit! Mike.Hammerton Thu, 07/11/2024 - 09:15 Bookmark this

Drug Development 52

Drug Development 52

Express Pharma

JULY 8, 2024

In June 2024, the pharma and healthcare industry reported 76 deals worth $5B, compared to the last 12-month (June 2023 to May 2024) average of 95 deals worth $19B. million; NewGenIvf Group, to acquire COVIRIX Medical, a clinical-stage pharmaceutical company developing novel antiviral therapies for $617.3

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Drug Development 105

pharmaphorum

FEBRUARY 9, 2024

Obesity & Weight Loss Drug Development Summit Mike.Hammerton Fri, 09/02/2024 - 16:24 Bookmark this

Drug Development 52

Drug Development 52

Express Pharma

APRIL 8, 2025

The new structure is designed to unify its bioprocess businesses and streamline services offered to pharmaceutical partners across drug development and manufacturing. In 2024, it completed a new Planova assembly plant in Nobeoka, Miyazaki, Japan, to ensure consistent global supply.

Pharmaceutical Manufacturing 76

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies Drug Development 76

pharmaphorum

NOVEMBER 6, 2024

Delve into the critical issues surrounding patients, partnerships, and the US election in 2024. Explore the impact on drug development, pricing, and patient access in this in-depth analysis.

Drug Development 52

Drug Development 52

pharmaphorum

SEPTEMBER 17, 2024

The 9th annual event returns to Boston in 2024, continuing to support drug developers of all sizes in advancing their novel biotherapeutics discovery and development, join us!

Drug Development 52

Drug Development 52

PharmaTech

FEBRUARY 21, 2024

Lipid-based formulations (LBFs) are complex mixtures of lipid, surfactant and solvent excipient, where the composition determines the potential impact of dispersion and digestion on drug solubilization.

Drug Development 52

Drug Development 52

Drug Patent Watch

DECEMBER 10, 2024

Generic drug development is a complex process that requires a deep understanding of regulatory requirements and guidelines. Regulatory expertise plays a crucial role in ensuring that generic drugs meet the necessary standards for quality, safety, and efficacy. ” Scientific Research Publishing , 2024. ” U.S.

Drug Development 52

Drug Development Communication 52

Outsourcing Pharma

OCTOBER 2, 2024

At CPHI Milan 2024, Ardena will showcase its latest advancements in drug development and manufacturing, including the launch of a state-of-the-art nanomedicines GMP facility in Oss, Netherlands.

Drug Development 52

Drug Development 52